[Insulin monotherapy in patients with diabetes mellitus type 2 developing secondary resistance to sulfanilamide preparations].
Patients with type-II diabetes mellitus differ widely in degrees of beta-cell functional activity, with some of them requiring insulinization as a corrective measure for hyperglycemia. It is a well-chosen and a propitious treatment option in those patients presenting with secondary resistance to sulfa drugs.